Company ProfilePremium

Qingdao Gon Technology Co., Ltd.

Company Profile Analysis

Ticker: 2768.HK青島國恩科技股份有限公司

ESOMAR 23 Corporate BadgeISO Certifications Badge
Qingdao Gon Technology Co., Ltd. - Company showcase

Year Founded & Workforce

2000

5,532 Employees

Qingdao Gon Technology Co., Ltd. logo

Qingdao Gon Technology Co., Ltd. Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Qingdao Gon Technology Co., Ltd. Overview

Gon Technology is a Qingdao-based, founder-controlled Chinese materials group that has built a vertically integrated chain running from monomers through synthetic resins (notably polystyrene) to modified polymer materials, polymer composites and finished components for automotive, home-appliance and new-energy-vehicle customers. According to its Hong Kong prospectus, it was China's second-largest producer of modified and composite polymer materials in 2024 with a 2.5% share [S7], China's largest polystyrene enterprise by capacity and the second-largest bone-gelatin producer [S11]. A second "wing" — biomedical and health — is anchored by its ChiNext-listed subsidiary Dongbao Bio (gelatin, collagen, hollow capsules). Revenue reached RMB 21.25bn in FY2025 [S12], and H1 2026 attributable profit rose 89% on upstream integration gains [S13]. In July 2026 management declared a third pillar — AI compute infrastructure and embodied-intelligence robotics — reframing Gon as a "high-end manufacturing + green compute + AI" platform, a pivot that materially raises its capital intensity and execution risk [S13][S19].


Company's own description. The HKEX company profile describes the principal business as R&D, production and sale of new chemical materials — green petrochemical new materials, organic polymer modified materials and organic polymer composite materials — plus R&D, production and sale of natural collagen and collagen-based products, including gelatin, collagen and derivatives, and hollow capsules [S5]. The IPO due-diligence summary adds that the group also operates a Health Industry segment and a Property Investment segment [S6].

Integrated value chain. Management frames the chemicals business as a full chain of "monomer → synthetic resin → organic polymer modification/composite materials → finished products" [S13]. The 2026 interim report lists the chain-extension projects underpinning this: a propylene-oxide (PO) co-production project, Gon Polymer's 1,000,000 t/yr polystyrene project, Hong Kong Petrochemical's 250,000 t/yr high-performance PS project, Rizhao Gon's 120,000 t/yr expandable PS (EPS) project, and a Jiangsu Guoheng project [S4].

Revenue model. Revenue is overwhelmingly product sales (B2B, contract and spot) rather than services, subscriptions or licensing. There is no disclosed licensing revenue; property investment income is minor and not separately quantified in the sources reviewed.

Customer types and end-markets. Industrial customers in automotive (including NEV battery-pack components, which management says reached volume production in 2026 [S16]), home appliances, packaging/insulation (EPS), electronics, and pharmaceuticals/nutraceuticals (capsules, gelatin, collagen) [S11]. Overseas revenue is small: RMB 303m in FY2025 (1.42% of total), rising to RMB 247m in H1 2026 (2.14%, +57.62% YoY) [S14].

Independent characterisation. Gon is best understood as a cost-advantaged, volume-driven converter that has spent 2022–2025 moving upstream to capture resin margins. The upstream "green petrochemical" line has gone from RMB 1.20bn of revenue in 2022 to RMB 5.29bn in 2025 [S19], and in H1 2026 its gross margin jumped by 7.30 points to 12.15% [S14] — the single largest driver of the profit inflection. The health wing provides diversification but is a small and lower-growth contributor. The July 2026 AI-compute pivot is a strategic departure rather than an adjacency, and it is too early to model.

Strategy

Stated strategy (FY2025 AR). Gon positions itself as a vertically integrated industrial platform with chemical new materials and biomedical/health as its "two wings". Its key moves are a precision "New Materials+" layout, a "Collagen+" upgrade, M&A of upstream raw materials, and the H-share listing as a globalisation capital base [S14].

Strategic shift (H1 2026 report). Management now describes a three-pillar "high-end manufacturing + green compute + AI" platform. AI compute construction/operations and robotics form the third growth pillar [S13]. The FY2025 AR had envisaged compute only as an in-house centre for robot training; the upgrade to a standalone pillar came faster than planned [S14].

Initiatives in the last 24 months

IPO use of proceeds: R&D, capacity expansion, brand promotion and strategic acquisitions [S11]. No numeric medium-term financial targets have been published. ESG targets are not publicly disclosed in sources reviewed.

Products & Services

Pricing models are not publicly disclosed. Materials are priced on commodity-linked, cost-plus terms (standard industry practice; not company-specific disclosure).

Product Portfolio

SegmentProduct lineDescription / capabilitiesTarget customersStatus / scaleSource

Green petrochemical

Polystyrene (GPPS/HIPS)

Commodity and high-performance PS resins; group claims China's largest PS capacity

Appliances, packaging, electronics

Gon Polymer 1,000,000 t/yr project; Hong Kong Petrochemical 250,000 t/yr high-performance PS

[S4][S11]

Green petrochemical

Expandable polystyrene (EPS)

Foamable beads for insulation and protective packaging

Construction, packaging

Rizhao Gon 120,000 t/yr

[S4]

Green petrochemical

Propylene oxide (PO) co-production

Upstream monomer/intermediate

Internal and external polyol/chemical users

Project disclosed; capacity not stated in sources reviewed

[S4]

Green petrochemical (planned)

High-purity dianhydride monomer, polyimide, high-purity p-methylstyrene

Upstream specialty monomers and high-performance polymers

Electronics, specialty materials

Under planning (Jul 2026)

[S16]

Modified materials

Modified engineering and general plastics

Compounded PP/ABS/PS/PC grades with flame-retardant, reinforced and weatherable properties (grade detail not disclosed)

Auto OEMs/Tier-1s, appliance makers

Largest revenue line, RMB 10.36bn in FY2025

[S14]

Composite materials

Polymer composites and parts

Fibre-reinforced and composite components

Automotive, NEV

RMB 3.92bn in FY2025

[S14]

Composite materials

NEV battery-pack products

Composite battery enclosures/components

NEV makers

Volume ramp in 2026

[S16]

Health

Gelatin (incl. bone gelatin)

Pharmaceutical and food gelatin; group claims #2 bone-gelatin producer in China

Pharma, food

Via Dongbao Bio

[S5][S11]

Health

Collagen and derivatives

Collagen peptides and consumer health products

Nutraceutical, consumer

Via Dongbao Bio

[S5]

Health

Hollow (empty) capsules

Gelatin hard capsules

Pharma, nutraceutical

Via group health businesses

[S5]

Health

Consumer nutrition range

Health foods, nutritional proteins, gut-health, weight-management and beauty products

Consumers

Disclosed in 2022 annual report

[S15]

Property

Property investment

Leasing income

—

Minor; not quantified

[S6]

AI/Robotics (new)

Green compute / intelligent computing centres

Compute hardware, AI data centres, green-power coordination

Enterprise/AI customers

Gon Jiuchi (Shanghai) formed Jul 2026

[S19]

AI/Robotics (new)

Biped and quadruped robots

Biped with high-torque lightweight servo joint modules, under 45 kg

Industrial/scene applications

R&D prototypes (May 2026)

[S16]

AI/Robotics (new)

E-skin, force-feedback teleoperation gloves

Sensing and teleoperation hardware

Robotics developers

Disclosed in H1 2026 report

[S16]

Financial Narrative

Income statement (RMB million)

FY2021 growth computed against FY2020 revenue of RMB 7.18bn and NP of RMB 731m [S15]. Revenue CAGR FY2021–FY2025: ≈21.5% (computed). Gross profit, operating income and EBITDA for full years were not disclosed in the sources reviewed.

Interim/quarterly trend (RMB million)

Sources: [S20][S23][S13][S19][S25]. H1 EPS is adjusted for the June 2026 4.8-for-10 bonus issue [S4]; Q1 EPS is pre-bonus. H1 2025 operating profit derived from the +100.82% growth rate.

Balance sheet (RMB million)

Source: [S15]: As at 30 June 2026 [S19][S27]:

Goodwill and intangibles, working capital, capex, FCF, buybacks executed, ROIC, interest coverage and cash conversion cycle were not publicly disclosed in sources reviewed. Operating cash flow per share was RMB 0.69 in Q1 2025 and RMB 0.44 in Q1 2026 (-36%) [S20][S23]. Book value per share was RMB 22.89 at Q1 2026 [S23].

Commentary. Three phases are visible.

FY2021–FY2023: scale without profit: Revenue more than doubled, but attributable profit fell from RMB 731m (FY2020) to RMB 471m (FY2023) as the group added low-margin upstream PS volume and absorbed acquisitions. Net margin compressed from roughly 10% to 2.7%.

FY2024–FY2025: recovery: Profit recovered on mix and modified-materials margin expansion (+2.80 points in FY2025), with ROE reaching 15.72%.

H1 2026: inflection: Upstream PS margins more than doubled, and the modified line saw both volume and price gains, lifting half-year net margin to 6.29% and annualised ROE to around 20%. Management explicitly attributes the gain to full-chain synergy [S25].

Two cautions apply. Operating cash flow lagged profit in Q1 2026, and receivables were flagged as large historically (Q1 2025 receivables were 412% of annual NP [S20]). Leverage is also rising into the compute pivot.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Revenue by Segment

Segment (CNY Mn)FY2022FY2024FY2025

Green petrochemical & new materials

1,1963,8695,290

Organic polymer modified materials

—10,32510,357

Organic polymer composite materials

—3,1753,917

Health, property & other (residual)

—1,8181,687

Total revenue

13,40619,18821,251

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Segment YoY growth (%)

Segment YoY growth (%)FY2025H1 2026

Green petrochemical & new materials

36.7247.14

Organic polymer modified materials

0.3111.57

Organic polymer composite materials

23.3618.48

Segment gross margin (%)

Segment gross margin (%)FY2024FY2025

Green petrochemical & new materials

4.845.84

Organic polymer modified materials

9.3612.16

Organic polymer composite materials

9.2612.81

Revenue by Segment (Half-Yearly)

Segment (CNY Mn)H1 2025H1 2026

Green petrochemical & new materials

1,9612,886

Organic polymer modified materials

4,9145,483

Organic polymer composite materials

1,7272,046

Total revenue

9,75411,514

Segment gross margin (%) (Half-Yearly)

Segment gross margin (%)H1 2025H1 2026

Green petrochemical & new materials

4.8512.15

Organic polymer modified materials

11.7314.02

Organic polymer composite materials

11.8114.46

Per-Share Data

MetricFY2021FY2022FY2023FY2024FY2025

Revenue (as originally reported)

9,766.013,406.417,438.819,187.521,251.0

Revenue (restated basis, aggregator)

——17,43919,22021,251

Pre-tax profit (as reported)

——577.9797.1—

Total profit (aggregator series)

——570785947

Attributable net profit (as reported)

642.9663.1471.5685.2841.0

Attributable net profit (restated basis)

——466676841

Recurring NP excl. non-recurring

630.1630.6———

Basic EPS (MYR Bn, pre-bonus basis)

2.372.441.722.523.17

DPS cash (MYR Bn)

—0.25——0.50

Growth & margins (%)

Growth & margins (%)FY2021FY2022FY2023FY2024FY2025

Revenue growth

35.9937.2830.0810.0310.57

Attributable NP growth

-12.033.14-28.8945.3324.38

Attributable net margin

6.584.952.703.573.96

Weighted ROE

————15.72

Margin Analysis (%) and Per-Share Data

MetricQ1 2025Q1 2026H1 2025H1 2026

Revenue

4,4125,3779,75411,514

Attributable net profit

111257345.9655

Operating profit

——385774

Gross margin (%)

8.8111.93——

Net margin (%)

2.585.053.566.29

Basic EPS (MYR Bn)

0.420.930.881.53

Financial Analysis

MetricFY2020FY2021FY2022

Total assets

5,461.59,908.912,753.1

Equity attributable to shareholders

3,097.73,476.04,072.1

Financial Analysis — Monetary funds

MetricValue (CNY Mn)

Monetary funds (货币资金)

4,018

Cash and cash equivalents

2,018

Short-term borrowings

1,819

Long-term borrowings

3,410

Non-current liabilities due within one year

1,358

Gross interest-bearing debt (sum of the above three)

6,587

Net debt vs monetary funds

2,569

Net assets

9,155

Guarantees to subsidiaries outstanding

4,795

Revenue by Region

Region (CNY Mn)FY2024FY2025

Overseas

304303

Mainland China (derived)

18,88420,948

Revenue by Region (Half-Yearly)

Region (CNY Mn)H1 2025H1 2026

Overseas

157247

Mainland China (derived)

9,59711,267

Share Price

MetricIPO (4 Feb 2026)Debut midday20 Sep 2026

H-share price (HKD)

36.0041.7841.60

Income Statement and Per-Share Data

MetricFY2025AFY2026EFY2027EFY2028E

Revenue (CNY Mn)

21,25125,99130,10538,087

Net profit (CNY Mn)

8411,1771,4861,972

EPS (MYR Bn, post-bonus)

—2.683.384.50

Broker

Date

FY2026E NP (RMB M)

FY2027E NP (RMB M)

—

China Galaxy

31 Aug 2026

1,2651,520—

Founder Securities

28 Aug 2026

1,2081,513—

Dongguan Securities

30 Mar 2026

9231,045—

Analyst Conclusions

Guidance. No formal numeric guidance has been issued. The H1 2026 profit alert range of RMB 600–750m was met at RMB 655m [S25][S13]. Consensus expects FY2026 NP of RMB 1.18bn (+40%) and revenue of RMB 26.0bn (+22%) [S26]. H1 2026 already represents 56% of that profit consensus.

Bull case

  1. Upstream integration is structural: green petrochemical GM rose from 4.85% to 12.15% YoY while volumes grew 47% [S14].

  2. Modified materials have re-accelerated (+11.57% in H1 2026 versus +0.31% in FY2025) with margin gains, and NEV battery-pack composites add a new growth vector [S14][S16].

  3. A 15.7% ROE (FY2025), rising toward 20% annualised, at an aggregator TTM EPS of 2.65 offers earnings momentum with dual-market liquidity [S12][S8].

Bear case

  1. Up to RMB 15bn of guarantees for an unproven AI-compute venture (1.64x net assets) risks capital destruction and a de-rating [S19].

  2. Liquidity is tight: RMB 6.59bn of gross debt and RMB 4.80bn of existing guarantees against RMB 4.02bn of monetary funds, with weakening operating cash flow [S27][S23].

  3. PS spreads are cyclical; FY2023 showed profit can fall nearly 30% despite revenue growth of 30% [S5].

Catalysts and monitorables (next 12 months). Q3 2026 results (late October); approval and drawdown of the Gon Jiuchi guarantee and the first compute capex; PS/PO project commissioning; NEV battery-pack volumes; operating cash flow versus profit; FY2026 dividend policy; any credit facility or bond issuance; and H-share index inclusion.

Analyst verdict. Gon Technology enters late 2026 with the best operating momentum in its history. A decade-long effort to integrate upstream into polystyrene and monomers is finally showing up in margins. H1 2026 net margin of 6.29% is almost double the prior-year 3.56% [S19], and the improvement is broad-based across all three chemical lines rather than a one-off gain. If FY2026 lands near the RMB 1.18bn consensus, earnings will have grown roughly 2.5x from the FY2023 trough in three years. The February 2026 H-share listing broadened the shareholder base and drew exceptional retail demand, and Stock Connect inclusion supports liquidity.

The investment case has, however, been complicated by management's own strategy. The July 2026 decision to make AI compute and robotics a third pillar, backed by a proposed guarantee capacity of up to RMB 15bn, introduces a binary capital-allocation risk into what had become a clean margin-recovery story. Gon has no disclosed competitive edge in data-centre operations. Its balance sheet already carries more short-dated debt and subsidiary guarantees than cash. Large-scale compute capex would push leverage materially higher just as the commodity cycle could turn.

Our synthesis: the core materials franchise appears undervalued on its own merits, provided the PS spread holds. The equity, however, will increasingly trade on investors' confidence in management's discipline around the compute venture. We would treat the stock as a positive-momentum but governance-sensitive holding. The key monitorables are the scale and financing structure of Gon Jiuchi's first projects, cash conversion, and whether the founder-controlled board sets explicit return hurdles. Clear ring-fencing of the compute business — for example via external partners or project finance — would materially de-risk the thesis. Open-ended parent guarantees would justify a governance discount despite strong operating results.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Board of Directors

NameRoleNotes

Wang Aiguo (王愛國)

Chairman & General Manager

Founder and controlling shareholder; also legal representative of Dongbao Bio

Li Zonghao (李宗好)

Executive Director

—

Li Huiying (李慧穎)

Executive Director

—

Han Bo (韓博)

Executive Director

—

Wang Yaping (王亞平)

Independent Non-Executive Director

—

Sun Jianqiang (孫建強)

Independent Non-Executive Director

—

Xiang Ting (項婷)

Independent Non-Executive Director

—

Yu Chuibai (于垂柏)

Head of accounting (as of 2022 AR)

—

Major Shareholders

HolderSharesClass% of total% of class

Wang Aiguo and connected persons

153,000,000

A

50.7956.41

First Seafront Fund Series SPC

3,055,400

H

1.0410.18

Zhou Wanyuan

2,361,000

H

0.807.87

SLD International Enterprises Ltd

2,222,200

H

0.757.41

Competitive Landscape

Competitors by Segment

SegmentNamed competitors (not exhaustive)

Modified plastics / composites (China)

Kingfa Sci & Tech (600143.SH), Shanghai Pret Composites (002324.SZ), Shenzhen Wote Advanced Materials (002886.SZ), Guangdong Silver Age Sci & Tech (300221.SZ), Polyrocks Chemical (688669.SH)

Polystyrene / EPS

Sinopec and CNPC affiliates; foreign-invested and private PS producers in East and South China

Gelatin / collagen

Rousselot (Darling Ingredients), Gelita, PB Leiner (Tessenderlo), Nitta Gelatin

Hard capsules

Lonza Capsugel, ACG, Suheung

Competitor Detail

Metric (FY2025)Gon

Revenue (CNY Mn)

21,251

Revenue growth (%)

10.57

Attributable net margin (%)

3.96

ROE (%)

15.72

Company Snapshot

$2,955.6M

Revenue

5,532

Employees

2000

Founded

Qingdao, China

Headquarters

SWOT Analysis

Strengths

  • #2 in Chinese modified/composite polymers with a 2.5% share in 2024 [S7].
  • Claimed #1 Chinese PS capacity, including a 1.0mt/yr project [S4][S11].
  • Integration-led margin uplift: green petrochemical GM +7.30pts to 12.15% in H1 2026 [S14].
  • Consistent growth: revenue CAGR of ≈21.5% over FY2021–FY2025 [S15][S12].
  • ROE of 15.72% in FY2025 [S12].
  • Diversified health wing via listed Dongbao (H1 2026 revenue RMB 415m) [S13].

Weaknesses

  • Thin margins: FY2025 attributable net margin of 3.96% (computed).
  • Combined Chairman/GM role and 50.79% founder control [S5].
  • Domestic concentration: overseas only 1.42% of FY2025 revenue [S14].
  • Large receivables (412% of annual NP in Q1 2025) [S20].
  • Weakening cash conversion: Q1 2026 operating cash flow per share -36% YoY [S23].
  • Modified-materials growth of only 0.31% in FY2025 [S14].

Opportunities

  • NEV battery-pack composites ramping [S16].
  • Specialty monomers and polyimide could raise mix value [S16].
  • Overseas revenue +57.6% in H1 2026 [S14].
  • Consensus 2026E NP of RMB 1.177bn (+40%) [S26].
  • Stock Connect eligibility broadens the H-share investor base [S3].
  • Robotics materials synergy (e-skin, joints) [S16].

Threats

  • Up to RMB 15bn guarantee exposure for an unproven compute business, versus net assets of RMB 9.16bn [S19].
  • More than RMB 3.1bn of debt due within 12 months, versus RMB 4.02bn of monetary funds [S27].
  • PS spread mean-reversion (FY2025 green petrochemical GM was only 5.84%) [S14].
  • Broker dispersion: 2026E NP forecasts range from RMB 923m to RMB 1.373bn [S26].
  • Existing subsidiary guarantees of RMB 4.80bn already exceed cash [S27].
  • Past profit volatility (-28.9% in FY2023) [S5].

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
Apr 2025Q1 2025: revenue -0.23%, NP -9.79% [S20]Cyclical trough
26 Jun 2025H-share application filed [S21]Dual-listing path
2025Huai'an Xinsheng acquired; Thailand and Shenzhen subsidiaries set up [S14]Upstream and overseas expansion
Jan 2026IPO launched at HK$34–42 for 30m shares [S11]Up to HK$1.26bn
4 Feb 2026H shares list at HK$36; retail tranche 2,251.85x, international 10.03x [S7]Strong demand
4 Feb 2026Midday close HK$41.78 (+16.06%) [S7]Positive debut
30 Mar 2026FY2025 results: revenue RMB 21.25bn, NP RMB 841m, ROE 15.72% [S12]Record revenue
30 Mar 2026Distribution proposal: RMB 5/10 shares + 4.8-for-10 bonus [S12]Shareholder returns
30 Mar 2026Dongguan Securities forecasts 2026 NP of RMB 923m [S26]Cautious broker view
28 Apr 2026Q1 2026: revenue +21.86%, NP +131.08%, GM 11.93% [S23]Inflection
10 May 2026Robotics and compute centre disclosed at investor briefing [S16]New narrative
9 Jun 2026AGM approves distribution [S22]—
18 Jun 2026A-share distribution completed [S22]—
Jul 2026Gon Jiuchi formed (AI compute) [S19]Strategic pivot
10 Jul 2026Profit alert: H1 NP RMB 600–750m [S25]Beat
15 Jul 2026Specialty monomer/polyimide plans disclosed [S16]Upstream specialty
16 Jul 2026H-share distribution completed [S22]—
28 Aug 2026H1 2026: revenue RMB 11.51bn, NP RMB 655m (+89.33%) [S13]Record half
28 Aug 2026Founder Securities: 2026E NP RMB 1.208bn [S26]Upgrade
31 Aug 2026China Galaxy: 2026E NP RMB 1.265bn [S26]Upgrade
Sep 2026Up to RMB 15bn guarantee for Gon Jiuchi proposed [S19]Leverage risk
14 Sep 2026Press scrutiny of debt (RMB 3.1bn+ due within 12 months) [S27]Sentiment risk
20 Sep 2026H shares at HK$41.60 [S8]—

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

4 charts
Revenue by Segment (FY2022–FY2025): Total revenue rose from CNY 13,406 Mn in FY2022 to CNY 21,251 Mn in FY2025.
Qingdao Gon Technology Co., Ltd. — Revenue by Segment (FY2022–FY2025)
Series (CNY Mn)FY2022FY2024FY2025
Total revenue13,40619,18821,251
Green petrochemical & new materials1,1963,8695,290
Organic polymer modified materials—10,32510,357
Organic polymer composite materials—3,1753,917
Health, property & other (residual)—1,8181,687

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Sources

Sources

  1. S1HKEX Trading Arrangement Notice, GON TECHNOLOGY (02768) New Listing (hkex.com.hk)
  2. S2Gon Technology 2026 First Quarterly Report (HKEX) (www1.hkexnews.hk)
  3. S3Simply Wall St, SEHK:2768 company information (simplywall.st)
  4. S4Gon Technology 2026 Interim Report (HKEX) (hkexnews.hk)
  5. S5ET Net company profile 02768 (content.etnet.com.hk)
  6. S6CBI, IPO due diligence note (cbil.com.hk)
  7. S7The Bamboo Works, trading debut (thebambooworks.com)
  8. S8Investing.com, Qingdao Gon Tech (2768) (uk.investing.com)
  9. S10Shanghai Securities News, FY2025 annual report summary (2026-03-31) (paper.cnstock.com)
  10. S11IPOX calendar, Gon Technology (ipox.com)
  11. S12Securities Times / Databao, FY2025 results and distribution (stcn.com)
  12. S13China Securities Journal, H1 2026 results (cs.com.cn)
  13. S14Stockstar, H1 2026 analysis (segments, overseas) (wap.stockstar.com)
  14. S15Gon 2022 Annual Report summary (China Securities Journal) (epaper.cs.com.cn)
  15. S1610jqka company overview 002768 (basic.10jqka.com.cn)
  16. S17Dongbao Bio 2022 Annual Report data (Pharnexcloud) (pharnexcloud.com)
  17. S18China Securities Journal disclosure, buyback plan (epaper.cs.com.cn)
  18. S19Huxiu / Caijing Sixianghui, RMB 15bn guarantee analysis (m.huxiu.com)
  19. S20Tencent News / Stockstar, Q1 2025 results (news.qq.com)
  20. S21China Securities Journal disclosure, H-share application (epaper.cs.com.cn)
  21. S22China Securities Journal, 2026 interim report summary (epaper.cs.com.cn)
  22. S23Stockstar, Q1 2026 results (stock.stockstar.com)
  23. S2410jqka / Zhitong, H1 profit alert (stock.10jqka.com.cn)
  24. S25China Securities Journal, H1 2026 profit alert filing (epaper.cs.com.cn)
  25. S2610jqka consensus forecasts 002768 (basic.10jqka.com.cn)
  26. S27Huxiu, debt and liquidity detail (huxiu.com)
  27. S28Shanghai Securities News, board resolutions (2026-03-31) (paper.cnstock.com)

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.